Viewing Study NCT06556004


Ignite Creation Date: 2025-12-24 @ 9:19 PM
Ignite Modification Date: 2026-04-06 @ 10:21 PM
Study NCT ID: NCT06556004
Status: UNKNOWN
Last Update Posted: 2024-08-15
First Post: 2024-08-12
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase 1 Study Using TRIMELVax for Stage IIIC / IV Melanoma Patients
Sponsor: University of Chile
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module